Transcription of Needle-Free Devices Latest Developments - WHO
{{id}} {{{paragraph}}}
Needle-Free Devices Latest Developments 11th WHO/UNICEF Consultation with OPV/IPV Manufacturers and National Regulatory Authorities WHO Geneva, Switzerland October 25, 2012 Darin Zehrung, MBA Senior Technical Officer Portfolio Leader, Delivery Technologies Vaccine Technologies Group PATH/Amynah Janmohamed Presentation Outline FDA Disposable Syringe Jet Injector (DSJI) Update FDA Communication on Jet Injectors Requirements for Jet Injectors and Vaccine Labeling PharmaJet (Stratis) Influenza Vaccine Study WHO DSJI Prequalification Update Device Developer Updates Bioject (ID Pen Injector, Zetajet) PharmaJet (Tropis) Planned Intradermal DSJI Research 1/14/2013 Page 2 FDA DSJI Update Slide 3 FDA Communication Jet Injectors Requirement for relabeling for jet injection - influenza vaccines and other medications / vaccines.
Needle-Free Devices – Latest Developments 11th WHO/UNICEF Consultation with OPV/IPV Manufacturers and National Regulatory Authorities WHO Geneva, Switzerland – October 25, 2012
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
LATEST DEVELOPMENTS, Design, NEW HOMES 2014, Latest, Geometric Design of Major/Minor Priority Junctions, Geometric design of major / minor priority junctions, Crime Prevention Through Environmental Design, Commercial Perspective on New Developments, Commercial Perspective on New Developments in Catalysis for Olefin Polymerization, Current developments in rotary root canal, Hazardous area, MTL5541